{"organizations": [], "uuid": "15c2292a489d344f78ff5aa2092e03bf716eff99", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180502.html", "section_title": "Archive News &amp; Video for Wednesday, 02 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-vanda-pharmaceuticals-inc-reports/brief-vanda-pharmaceuticals-inc-reports-qtrly-eps-of-0-06-idUSFWN1S917U", "country": "US", "domain_rank": 408, "title": "BRIEF-Vanda Pharmaceuticals Inc Reports Qtrly EPS Of $0.06", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.495, "site_type": "news", "published": "2018-05-03T04:21:00.000+03:00", "replies_count": 0, "uuid": "15c2292a489d344f78ff5aa2092e03bf716eff99"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-vanda-pharmaceuticals-inc-reports/brief-vanda-pharmaceuticals-inc-reports-qtrly-eps-of-0-06-idUSFWN1S917U", "ord_in_thread": 0, "title": "BRIEF-Vanda Pharmaceuticals Inc Reports Qtrly EPS Of $0.06", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "vanda pharmaceuticals inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "brief-vanda pharmaceuticals inc", "sentiment": "negative"}, {"name": "fina", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 2 (Reuters) - Vanda Pharmaceuticals Inc:\n* VANDA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* VANDA PHARMACEUTICALS INC - TOTAL NET PRODUCT SALES WERE $43.6 MILLION IN Q1 OF 2018\n* VANDA PHARMACEUTICALS INC - REITERATES 2018 NET PRODUCT SALES GUIDANCE OF $180 MILLION TO $200 MILLION\n* VANDA PHARMACEUTICALS INC QTRLY NON-GAAP NET INCOME WAS $0.14 PER SHARE\n* VANDA PHARMACEUTICALS INC QTRLY EARNINGS PER SHARE $0.06 Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-03T04:21:00.000+03:00", "crawled": "2018-05-03T12:37:32.001+03:00", "highlightTitle": ""}